Sight Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

Sight Sciences

05/03/2025 23:29

Sight Sciences Inc SGHT.OQ reported a quarterly adjusted loss of 23 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -22 cents.  The mean expectation of eight analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -31 cents to -9 cents per share.

Revenue rose 1.7% to $19.07 million from a year ago; analysts expected $19.80 million.

Sight Sciences Inc's reported EPS for the quarter was a loss of 23 cents​.

The company reported a quarterly loss of $11.85 million.

Sight Sciences Inc shares had fallen by 32.1% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 8.3% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Sight Sciences Inc is $4.00

This summary was machine generated from LSEG data March 5 at 11:29 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.20
-0.23
Missed
Sep. 30 2024
-0.21
-0.22
Missed
Jun. 30 2024
-0.30
-0.25
Beat
Mar. 31 2024
-0.28
-0.33
Missed